3 reasons why Indian pharma is getting ready for unstoppable growth
In today’s dynamic market, we frequently witness indices scaling new heights, with the latest milestone being the Nifty crossing 25,000 mark. Amidst these high valuations, one sector stands out with strong growth potential—the Indian pharmaceutical industry. Often seen as a contrarian or defensive investment, this sector provides a powerful hedge against market volatility while energizing…
READ MORE
Patent cliff can turn Indian pharma stocks into investor’s goldmine
Over the past few months, the market witnessed a sharp rally in pharma sector stocks, one of the key drivers behind this surge is ‘Patent Cliff.’ A Patent cliff occurs when a significant number of drug patents expire and other companies are allowed to manufacture similar drug. Typically, the patent of a drug lasts for…
READ MORE